Search Within

Genitourinary Oncology Service

Formats
  1. Journal Article (2795)
  2. Meeting Abstract (2524)
  3. Review (119)
  4. Book Section (83)
  5. Editorial (57)
  6. Correspondence (34)
  7. Conference Paper (29)
  8. Guidelines (25)
  9. Research Letter (18)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Solid Tumor Oncology Division (5692)
  2. Department of Medicine (5682)
  3. GSK Faculty (1658)
  4. Human Oncology and Pathogenesis Program (1157)
  5. Department of Pathology and Laboratory Medicine (1129)
  6. Surgery (1021)

More Groups

People
  1. Robert Motzer (1252)
  2. Howard Scher (1133)
  3. David Solit (785)
  4. Dean Bajorin (664)
  5. Michael Morris (587)
  6. Jonathan Rosenberg (525)

More People

Years
  1. 2025 (200)
  2. 2024 (294)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1713)
  2. Annals of Oncology (304)
  3. Clinical Cancer Research (283)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (123)

More Publications

Publishers
  1. American Society of Clinical Oncology (1780)
  2. American Association for Cancer Research (689)
  3. Oxford University Press (414)
  4. Elsevier Science, Inc. (396)
  5. Elsevier Inc. (380)
  6. Nature Publishing Group (302)

More Publishers

Results (5692)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic characterization of bladder cancer with variant histology
    Meeting Abstract

    Lenis, A. T.; Clinton, T. N.; Hu, W.; Almassi, N.; Reisz, P.; Truong, H.; Thomas, J.; Nagar, K.; Goh, A.; Cha, E. K.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Identification of prognostic and predictive biomarkers of overall survival (OS) and progression-free survival (PFS) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with docetaxel, prednisone (DP) +/- bevacizumab (B) in CALGB 90401 (Alliance)
    Meeting Abstract

    Halabi, S.; Yang, Q.; Starr, M. D.; Brady, J. C.; Armstrong, A. J.; George, D. J.; Kelly, W. K.; Beltran, H.; Morris, M. J.; Nixon, A. B.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Phase I study of AMG 509, a STEAP1 x CD3 T-cell recruiting XmAb 2+1 immune therapy, in patients with metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Kelly, W. K.; Pook, D. W.; Appleman, L. J.; Waterhouse, D. M.; Horvath, L.; Edenfield, W. J.; Matsubara, N.; Danila, D. C.; Aggarwal, R. R.; Petrylak, D. P.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • A prospective phase II/III study of PSMA-targeted 18F-DCFPyL-PET/CT in patients (pts) with prostate cancer (PCa) (OSPREY): A subanalysis of disease staging changes in PCa pts with recurrence or metastases on conventional imaging
    Meeting Abstract

    Durack, J. C.; Alva, A. S.; Preston, M. A.; Pouliot, F.; Saperstein, L.; Carroll, P. R.; Pienta, K. J.; Rowe, S. P.; Patnaik, A.; Probst, S.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • A phase I trial of chemoimmunotherapy combining bacillus Calmette-Guerin (BCG) and intravesical gemcitabine for patients with BCG-relapsing high-grade nonmuscle-invasive bladder cancer
    Meeting Abstract

    De Jesus Escano, M. R.; Sjoberg, D. D.; McCarter, M.; McGill, M.; Goh, A.; Donahue, T. F.; Donat, M. S.; Cha, E. K.; Herr, H. W.; Meraney, A. M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Paclitaxel, ifosfamide & cisplatin (TIP) as second-line therapy for germ cell tumors (GCT):Long-term follow-up and expansion cohort
    Meeting Abstract

    Gleeson, J. P.; Knezevic, A.; Bromberg, M.; Patil, S.; Sheinfeld, J.; Carver, B. S.; Jones, D. R.; Bains, M. S.; Bajorin, D. F.; Bosl, G. J.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Significance of targeting the antiapoptotic pathway in castration-sensitive prostate cancer
    Meeting Abstract

    Chakraborty, G.; Hirani, R.; Nandakumar, S.; Kalidindi, T. M.; Fidele, D.; Rajanala, S. H.; Mazzu, Y. Z.; Yoshikawa, Y.; Jehane, L. E.; Lee, G. S. M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Patient-reported outcomes of patients with advanced renal cell carcinoma (aRCC) treated with first-line nivolumab plus cabozantinib versus sunitinib: The CheckMate 9ER trial
    Meeting Abstract

    Cella, D.; Choueiri, T. K.; Blum, S. I.; Ejzykowicz, F.; Hamilton, M.; Zhang, J.; Ivanescu, C.; Motzer, R. J.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Evaluating the role of stereotactic body radiation therapy with respect to androgen receptor signaling inhibitors for metastatic prostate cancer
    Meeting Abstract

    Brennan, V.; Spektor, A.; Sweeney, C.; Choudhury, A. D.; Rathkopf, D. E.; Pomerantz, M.; Hertan, L. M.; Martin, N. E.; Nguyen, P. L.; Balboni, T. A.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • A pilot study of preoperative nivolumab in high-risk nonmetastatic renal cell carcinoma
    Meeting Abstract

    Carlo, M. I.; Attalla, K.; Patil, S.; Murray, S. J.; Chen, Y. B.; Kotecha, R.; Durack, J. C.; Motzer, R. J.; Hakimi, A. A.; Voss, M. H.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save